A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Tempus AI
Actym Therapeutics, Inc.
Pfizer
NuCana plc
University of Virginia
Telix Pharmaceuticals (Innovations) Pty Limited
Pfizer
Elevation Oncology
ADC Therapeutics S.A.
University of Florida
pharmaand GmbH
Fate Therapeutics
Genmab
National Institutes of Health Clinical Center (CC)
Incyte Corporation
University of Wisconsin, Madison
Maastricht Radiation Oncology
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)
Auron Healthcare GmbH
GlaxoSmithKline
University of Wisconsin, Madison